Form 4: EHC COO Tuer Reports Stock Option Grant, Tax Withholding

Encompass Health Corp's EVP and COO, Patrick W. Tuer, reported the acquisition of stock options and the disposition of shares for tax obligations.

Summary

• Patrick W. Tuer, EVP, Chief Operating Officer of Encompass Health Corp (EHC), reported transactions involving company stock.
• On February 28, 2026, Tuer disposed of 545 shares of Encompass Health Common Stock at a price of $107.88 per share.
• These shares were withheld or surrendered to cover tax withholding obligations incurred in connection with the vesting of related restricted stock.
• Following this transaction, Tuer beneficially owns 25,437 shares of common stock directly.
• On March 2, 2026, Tuer was granted 10,502 non-qualified stock options (right to buy) with an exercise price of $108.06 per share.
• These options become exercisable in equal annual installments over a three-year period, commencing March 2, 2027, and expire on March 2, 2036.
• After this grant, Tuer beneficially owns 10,502 derivative securities (options) directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard executive compensation practices that align management incentives with long-term company performance, despite a minor share disposition for tax purposes.

Positives

• The grant of 10,502 non-qualified stock options aligns the EVP, Chief Operating Officer's interests with long-term shareholder value.
• The exercise price of $108.06 for the new options is consistent with the market price around the grant date, indicating a standard compensation award.

Negatives

• The disposition of 545 shares of common stock, valued at $107.88 per share, reduces direct common stock ownership, although this was for tax obligations.

Future Outlook

The granted stock options will become exercisable in equal annual installments over a three-year period, starting March 2, 2027, providing a long-term incentive for the executive.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as the grant of stock options and the disposition of shares for tax purposes, are common practices in executive compensation across the healthcare industry. These actions typically aim to align executive incentives with shareholder interests and manage tax liabilities associated with equity awards.

Stakeholder Impact

• Shareholders: The grant of stock options aligns the EVP, Chief Operating Officer's financial interests with long-term shareholder value creation. The disposition of shares for tax purposes is a routine event and has minimal impact.

Next Steps

• The granted stock options will begin to vest in equal annual installments starting March 2, 2027.
• The options will remain exercisable until their expiration date of March 2, 2036.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions, specifically the grant of stock options as part of executive compensation and the disposition of shares to cover tax obligations. Such standard events typically do not provide new material information that would warrant a change in investment recommendation. The transactions reflect ongoing executive incentive alignment rather than a significant shift in company fundamentals or outlook.

Keywords

Encompass Health Corp, EHC, Insider Trading, Form 4, Stock Options, Executive Compensation, Patrick W. Tuer, Common Stock, Tax Withholding